231 related articles for article (PubMed ID: 33301779)
1. Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine.
Eeltink E; van der Horst MZ; Zinkstok JR; Aalfs CM; Luykx JJ
Neurosci Biobehav Rev; 2021 Feb; 121():119-127. PubMed ID: 33301779
[TBL] [Abstract][Full Text] [Related]
2. Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.
Murray GK; Lin T; Austin J; McGrath JJ; Hickie IB; Wray NR
JAMA Psychiatry; 2021 Feb; 78(2):210-219. PubMed ID: 33052393
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype?
Fusar-Poli L; Rutten BPF; van Os J; Aguglia E; Guloksuz S
Int Rev Psychiatry; 2022; 34(7-8):663-675. PubMed ID: 36786114
[TBL] [Abstract][Full Text] [Related]
4. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
[TBL] [Abstract][Full Text] [Related]
5. Polygenic risk score as clinical utility in psychiatry: a clinical viewpoint.
Ikeda M; Saito T; Kanazawa T; Iwata N
J Hum Genet; 2021 Jan; 66(1):53-60. PubMed ID: 32770057
[TBL] [Abstract][Full Text] [Related]
6. Communicating polygenic risk scores in the familial breast cancer clinic.
Das Gupta K; Gregory G; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; McInerney-Leo A; Young MA; James PA; Yanes T
Patient Educ Couns; 2021 Oct; 104(10):2512-2521. PubMed ID: 33706980
[TBL] [Abstract][Full Text] [Related]
7. Polygenic risk scores in atrial fibrillation: Associations and clinical utility in disease prediction.
Gibson JT; Rudd JHF
Heart Rhythm; 2024 Jun; 21(6):913-918. PubMed ID: 38336192
[TBL] [Abstract][Full Text] [Related]
8. Polygenic risk scores in psychiatry: Will they be useful for clinicians?
Fullerton JM; Nurnberger JI
F1000Res; 2019; 8():. PubMed ID: 31448085
[TBL] [Abstract][Full Text] [Related]
9. Towards clinical utility of polygenic risk scores.
Lambert SA; Abraham G; Inouye M
Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer polygenic risk scores in the clinical cancer genetic counseling setting: Current practices and impact on patient management.
McGuinness M; Fassi E; Wang C; Hacking C; Ellis V
J Genet Couns; 2021 Apr; 30(2):588-597. PubMed ID: 33124135
[TBL] [Abstract][Full Text] [Related]
11. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
12. Taking the risk. A systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores.
Andreoli L; Peeters H; Van Steen K; Dierickx K
Am J Med Genet A; 2024 Jul; 194(7):e63584. PubMed ID: 38450933
[TBL] [Abstract][Full Text] [Related]
13. Exploration of experiences with and understanding of polygenic risk scores for bipolar disorder.
Putt S; Yanes T; Meiser B; Kaur R; Fullerton JM; Barlow-Stewart K; Schofield PR; Toma C; Peay H; Mitchell PB
J Affect Disord; 2020 Mar; 265():342-350. PubMed ID: 32090758
[TBL] [Abstract][Full Text] [Related]
14. A principal component approach to improve association testing with polygenic risk scores.
Coombes BJ; Ploner A; Bergen SE; Biernacka JM
Genet Epidemiol; 2020 Oct; 44(7):676-686. PubMed ID: 32691445
[TBL] [Abstract][Full Text] [Related]
15. How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?
Moorthy T; Nguyen H; Chen Y; Austin J; Smoller JW; Hercher L; Sabatello M
Am J Med Genet B Neuropsychiatr Genet; 2023; 192(7-8):161-170. PubMed ID: 37158703
[TBL] [Abstract][Full Text] [Related]
16. Uptake of polygenic risk information among women at increased risk of breast cancer.
Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA
Clin Genet; 2020 Mar; 97(3):492-501. PubMed ID: 31833054
[TBL] [Abstract][Full Text] [Related]
17. The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review.
Kumuthini J; Zick B; Balasopoulou A; Chalikiopoulou C; Dandara C; El-Kamah G; Findley L; Katsila T; Li R; Maceda EB; Monye H; Rada G; Thong MK; Wanigasekera T; Kennel H; Marimuthu V; ; Williams MS; Al-Mulla F; Abramowicz M
Hum Genet; 2022 Nov; 141(11):1697-1704. PubMed ID: 35488921
[TBL] [Abstract][Full Text] [Related]
18. Polygenic risk scores: how much do they add?
Christoffersen M; Tybjærg-Hansen A
Curr Opin Lipidol; 2021 Jun; 32(3):157-162. PubMed ID: 33900274
[TBL] [Abstract][Full Text] [Related]
19. From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer.
Wray NR; Lin T; Austin J; McGrath JJ; Hickie IB; Murray GK; Visscher PM
JAMA Psychiatry; 2021 Jan; 78(1):101-109. PubMed ID: 32997097
[TBL] [Abstract][Full Text] [Related]
20. Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk.
Palk AC; Dalvie S; de Vries J; Martin AR; Stein DJ
Philos Ethics Humanit Med; 2019 Feb; 14(1):4. PubMed ID: 30813945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]